EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis

Dominic Denk, Mallika Ramakrishnan, Claire Conche, Charles Pallangyo, Marina Pesic, Fatih Ceteci, Kilian B Kennel, Asude C Kirisözü, Esther Engel, Kathleen Mohs, Birgit Ritter, Angeles Macias Pardo und 5 weitere

Immunity · 2025

DOI: 10.1016/j.immuni.2025.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025. Verfasst von Dominic Denk und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany; Goethe University Frankfurt, University Hospi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Receptors, Interleukin-17, Carcinogenesis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Expression of interleukin (IL)-17 family cytokines is associated with tumor-promoting inflammation. We found that low expression of IL17RA associated with worse prognosis in late-stage colorectal cancer (CRC) patients. Deletion of Il17ra in intestinal epithelial cells (IECs) in a murine model of CRC enhanced epithelial-to-mesenchymal transition (EMT) via increased expression of the epidermal growth factor receptor and subsequent activation of the kinase Src. Yet, these mice were protected from metastatic disease; Il17ra deletion impaired intestinal barrier function and enhanced systemic fungal invasion and associated immunity. However, in macrophages, IL-17RA was required for spleen tyrosine kinase (Syk) activation upon fungal-induced dectin-1 engagement, and Il17ra ablation impaired IL-18 release and protective CD8+ T cell-mediated anti-tumor immunity. Combining recombinant IL-17 and heat-killed Candida albicans rendered colorectal tumors sensitive to α-PD-1 treatment in a model of microsatellite stable (MSS) CRC. Thus, IL-17RA engages two distinct tumor-suppressive mechanisms in CRC, linking EMT and fungal-induced anti-tumor immunity during tumor progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsReceptors, Interleukin-17CarcinogenesisAnimalsMiceSignal TransductionHumansEpithelial-Mesenchymal TransitionMice, KnockoutInterleukin-17Mice, Inbred C57BLCandida albicansDisease Models, AnimalCD8-Positive T-LymphocytesMacrophages

Stichwörter der Autor:innen

CRCEMTIL-17IL-17RAanti-tumor immunitycolon cancerimmunotherapyinflammationmycobiome

Substanzen

Receptors, Interleukin-17Il17ra protein, mouseInterleukin-17

Autor:innen und Institutionen

  • Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany; Goethe University Frankfurt, University Hospital, Medical Clinic 1, 60590 Frankfurt/Main, Germany.
  • Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany.
  • Gut Microbes and Health Institute Strategic Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK; Decoding Biodiversity, Earlham Institute, Norwich NR4 7UZ, Norfolk, UK.
  • Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Frankfurt Canc…

Förderung

  • Biotechnology and Biological Sciences Research Council
  • European Research Council

Zitieren

APA

Denk, D., Ramakrishnan, M., Conche, C., Pallangyo, C., Pesic, M., Ceteci, F., Kennel, K. B., Kirisözü, A. C., Engel, E., Mohs, K., Ritter, B., Pardo, A. M., Özkurt, E., Hildebrand, F., Waisman, A., Arkan, M. C., & Greten, F. R. (2025). IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis. Immunity. https://doi.org/10.1016/j.immuni.2025.02.005

Vancouver

Denk D, Ramakrishnan M, Conche C, Pallangyo C, Pesic M, Ceteci F, et al. IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis. Immunity. 2025. doi:10.1016/j.immuni.2025.02.005

BibTeX
@article{Denk2025,
  author = {Denk, Dominic and Ramakrishnan, Mallika and Conche, Claire and Pallangyo, Charles and Pesic, Marina and Ceteci, Fatih and Kennel, Kilian B and Kirisözü, Asude C and Engel, Esther and Mohs, Kathleen and Ritter, Birgit and Pardo, Angeles Macias and Özkurt, Ezgi and Hildebrand, Falk and Waisman, Ari and Arkan, Melek C and Greten, Florian R},
  title = {IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis},
  journal = {Immunity},
  year = {2025},
  doi = {10.1016/j.immuni.2025.02.005}
}
Kostenlos starten →